Dyslipidemia in type II diabetes mellitus - An assessment of the main lipoprotein abnormalities

Bangladesh Journal of Medical Science

Volumn 15, Issue 1, 2016, Pages 99-102

  Goel, Seema ^a   Garg, Prem Kumar ^b   Malhotra, Varun ^c   Madan, Jyotsna ^c   Mitra, Subir K ^c   Grover, Shruti ^a  

^a SANTOSH MEDICAL COLLEGE   (India)

^b Chirayu Medical College Hospital   (India)

^c NONE

Author keywords

Cholesterol; Dyslipidaemia; Lipid profile; Type II diabetes mellitus

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84963568768     PISSN: 22234721     EISSN: 20760299     Source Type: Journal    
DOI: 10.3329/bjms.v15i1.21170     Document Type: Article

References (20)

1. Fraser HS. The dilemma of diabetes: health care crisis in Caribbean. Rev PanamSaludPublica. 2001; 9:61-4.
2. Manu A, Shyamal K, Sunil G, Sandhu JS. A study on the lipid profile and the body fat in patients with diabetes mellitus. Anthropologist 2007; 4:295-8.
3. King H, Aubert RE, Herman WH. The global burden of diabetes (1995-2025) and its prevelance, numerical estimates and projection. Diabetic care 1998; 21:1414-31.
4. Miller M. The epidemiology of triglycerides as a coronary artery disease risk factor. Clin. Cardiol 1999; 22(suppl.11):111-16..
5. The American Diabetes Association. The management of dyslipidemia in adults with diabetes. Diabetic care 1999; 22 (suppl-I):S56-S59.
6. Beckman JA, Creager M, Libby P. Diabetes and atherosclerosis, Epid, Pathophysiology, and management: Review article. JAMA.2002;287(19):2570-81.
7. Navab M, Berliner JA, Watson AD, Navab M, Berliner JA et al. The yin and yang of oxidation in the development of the fatty streaks: A review based on the 1994 George Lyman Duff Memorial Lecture. ArteriosclerThrombVasc Biol.1996; 16:831-42.
8. Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein J, Witztum JL. Lipoprotein management in patients with cardiometabolic risk. Consensus statement from the American Diabetes Association and the American college of Cardiology foundation. Diabetic care 2008;31:811-822.
9. Sani –Bello F, Bakari AG, Anumah FE:sDyslipidemia in persons with type 2 diabetes mellitus in Kaduna Nigeria. Int J Diabetes and Metabolism 2007,15:9-13.
10. Sing IM, Shishehbor Do, Ansell BJ: High density lipoprotein as a therapeutic target:a systematic review. JAMA 2007;298:786-798.
11. Idogun ES, Unuigbe EP, Ogunro PS, Akinola OI, Famodu AA: Assessment of serum lipids in Nigerians with type 2 diabetes mellitus complications. Pak J Med Sci 2007,23:708-712.
12. O’Keefe JH, Cordian L, Harris WH, Moe RM, Vogel R. Optimal low density lipoprotein is 50-70mg/dl: lower is better and physiologically normal. J Am CollCardiol 2004;43:2142-2146.
13. Abell LL, Levy BB,Brodie BB, Kendall FE: Simplified methods for the estimation of total cholesterol in serum and demonstration of specificity. J BiolChem 1952;195:357-66.
14. Lepoz-Virella ML:Cholesterol determination in high density lipoproteins separated by three different methods. ClinChem 1977;23:882-90.
15. Bucolo G, David H:Quantitative determination of serum triglycerides by the use of enzymes. ClinChem 1973;19:476-82.
16. Friedwald WT, Levy RI, Friedrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma,without use of the preparative ultra centrifuge. Clin Chem 1972;18:499-502.
17. Trinder P.Determination of blood glucose by using 4-aminophenazone as an oxygen acceptor. J.Clin.Path 1969;22:246.
18. American diabetes Association: Standards of medical care in Diabetics-2009. Diabetes Care 2009;32:S13-S61.
19. Alberti KGMM. IDF Consensus on the metabolic syndrome:Definition and treatment.[http://www.idf. org/webcast]website.
20. The National Cholesterol Education Program[NCEP]. Expert panel on the detection,evaluation and the treatment of high blood cholesterol in adults.[Adult treatment panel III]. JAMA 2001;285:2486-97.